Abstract
Background
Cord blood lipids are potential disease biomarkers. We aimed to determine if their concentrations were affected by delayed blood processing.
Method
Refrigerated cord blood from six healthy newborns was centrifuged every 12 h for 4 days. Plasma lipids were analysed by liquid chromatography/mass spectroscopy.
Results
Of 262 lipids identified, only eight varied significantly over time. These comprised three dihexosylceramides, two phosphatidylserines and two phosphatidylethanolamines whose relative concentrations increased and one sphingomyelin that decreased.
Conclusion
Delay in separation of plasma from refrigerated cord blood has minimal effect overall on the plasma lipidome.
References
Alshehry, Z. H., Barlow, C. K., Weir, J. M., Zhou, Y., McConville, M. J., & Meikle, P. J. (2015). An efficient single phase method for the extraction of plasma lipids. Metabolites, 5(2), 389–403.
Birge, R. B., Boeltz, S., Kumar, S., Carlson, J., Wanderley, J., Calianese, D., et al. (2016). Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer. Cell Death Differ, 23(6), 962–978.
Chatterjee, S., & Pandey, A. (2008). The Yin and Yang of lactosylceramide metabolism: implications in cell function. Biochim Biophys Acta, 1780(3), 370–382.
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., et al. (2004). Bioconductor: open software development for computational biology and bioinformatics. Genome Biology, 5(10), R80.
Huynh, K., Pernes, G., Mellett, N. A., Meikle, P. J., Murphy, A. J., & Lancaster, G. I. (2018). Lipidomic profiling of murine macrophages treated with fatty acids of varying chain length and saturation status. Metabolites, 8(2), 29
Janssen, B. G., Madlhoum, N., Gyselaers, W., Bijnens, E., Clemente, D. B., Cox, B., et al. (2017). Cohort profile: The ENVIRonmental influence ON early AGEing (ENVIRONAGE): A birth cohort study. International Journal of Epidemiology, 46(5), 1386–1387.
Kamlage, B., Maldonado, S. G., Bethan, B., Peter, E., Schmitz, O., Liebenberg, V., et al. (2014). Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling. Clinical Chemistry, 60(2), 399–412.
Kamlage, B., Neuber, S., Bethan, B., Gonzalez Maldonado, S., Wagner-Golbs, A., Peter, E., et al. (2018) Impact of prolonged blood incubation and extended serum storage at room temperature on the human serum metabolome. Metabolites, 8(1), 6.
Lee, H. S., Burkhardt, B. R., McLeod, W., Smith, S., Eberhard, C., Lynch, K., et al. (2014). Biomarker discovery study design for type 1 diabetes in The Environmental Determinants of Diabetes in the Young (TEDDY) study. Diabetes/Metabolism Research and Reviews, 30(5), 424–434.
Lentz, B. R. (2003). Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Progress in Lipid Research, 42(5), 423–438.
Meikle, P. J., Wong, G., Barlow, C. K., & Kingwell, B. A. (2014). Lipidomics: potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease. Pharmacology & Therapeutics, 143(1), 12–23.
Penno, M. A., Couper, J. J., Craig, M. E., Colman, P. G., Rawlinson, W. D., Cotterill, A. M., et al. (2013). Environmental determinants of islet autoimmunity (ENDIA): A pregnancy to early life cohort study in children at-risk of type 1 diabetes. BMC Pediatrics, 13, 124.
Penno, M. A., Thomson, R. L., & Couper, J. J. (2016). Bunbury to Bundaberg, Darwin to Dover: Establishing a successful regional participation program for the ENDIA type 1 diabetes cohort study. Medical Journal of Australia, 205(10), 486.
Schutters, K., & Reutelingsperger, C. (2010). Phosphatidylserine targeting for diagnosis and treatment of human diseases. Apoptosis, 15(9), 1072–1082.
Vuillermin, P., Saffery, R., Allen, K. J., Carlin, J. B., Tang, M. L., Ranganathan, S., et al. (2015). Cohort profile: The Barwon infant study. International Journal of Epidemiology, 44(4), 1148–1160.
Yamato, K., & Yoshida, A. (1982). Biosynthesis of lactosylceramide and paragloboside by human lactose synthase A protein. Journal of Biochemistry, 92(4), 1123–1127.
Acknowledgements
We thank and Ngaire Elwood and Linda Chilcott for assistance with cord blood collection. This research was supported by the Juvenile Diabetes Research Foundation (JDRF) Australia, the Australian Research Council Special Research Initiative in Type 1 Juvenile Diabetes, The Helmsley Charitable Trust, JDRF International, and the National Health and Medical Research Council (NHMRC) of Australia (Program Grants 1037321 and 1054618). LCH is the recipient of a NHMRC Senior Principal Research Fellowship (1080887). The work was made possible through Victorian State Government Operational Infrastructure Support and NHMRC Research Institute Infrastructure Support Scheme.
Author information
Authors and Affiliations
Consortia
Contributions
The study was devised by JMW, MASP and LCH, who with EB-S arranged sample collection and storage. Lipid data were generated by KK and analysed by KK and NGB. JMW and LCH drafted the manuscript and all authors contributed to the final version.
Corresponding author
Ethics declarations
Conflict of interest
No author has a conflict of interest to declare.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Rights and permissions
About this article
Cite this article
Wentworth, J.M., Bediaga, N.G., Penno, M.A.S. et al. Minimal variation of the plasma lipidome after delayed processing of neonatal cord blood. Metabolomics 14, 130 (2018). https://doi.org/10.1007/s11306-018-1434-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11306-018-1434-9